Patient leaflet - Aquipta 60 mg tablets
1. What AQUIPTA is and what it is used for
AQUIPTA contains the active substance atogepant.
How AQUIPTA works
AQUIPTA works by blocking the activity of the calcitonin gene- related peptide (CGRP) molecule which has been linked to migraine. This reduction in CGRP’s activity reduces migraine attacks.
Mock-Up-Package-Leaflet-Aquipta-10mg + 60mg
20098876 10 mg tablets 60 mg tablets atogepant
What AQUIPTA is used for
AQUIPTA is used in adult patien
ts to:
Pregnancy, breast-feeding and fertility
AQUIPTA is not recommended during pregnancy.
treat an active migraine atta
ck
prevent migraine in those w
ho have at least 4 migraine days
per month
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before using this medicine.
2. What you need to know b
efore you take AQUIPTA
Do not take AQUIPTA
Driving and using machines
AQUIPTA may make you feel sleepy. Do not drive or use machines if you are affected.
If you are allergic to atogep
ant or any of the other
ingredients of this medicine
(listed in section 6).
Warnings and precautions
Talk to your doctor, pharmacist especially if you:
or nurse before taking AQUIPTA,
AQUIPTA contains sodium
This medicine contains 31.5 mg sodium (main component of cooking/table salt) in each 60 mg tablet. This is equivalent to 1.6% of the recommended maximum daily dietary intake of sodium for an adult.
- have liver problems
have kidney problems
This medicine contains less than 1 mmol sodium (23 mg) per
10 mg tablet, that is to say essentially ‘sodium-free’.
Allergic reactions
Stop taking AQUIPTA and tell y experience any symptoms of an • difficulty breathing
our doctor immediately if you allergic reaction such as:
- swelling of the face
3. How to take AQUIPTA
Always take this medicine exactly as your doctor has told you. Speak to your doctor or pharmacist if you are not sure.
- rash, itching, or hives
Some of these symptoms can o AQUIPTA.
ccur several days after you take
Children and adolescents
Do not give this medicine to chi years old) because the use of A this age group.
ldren or adolescents (under 18 QUIPTA has not been studied in
How much to take
The maximum dose per day is 60 mg.
For treatment of a migraine attack as needed, the recommended dose is 60 mg.
For prevention of migraine, the recommended dose is 60 mg once a day.
Other medicines and AQUIPT
A
Tell your doctor or pharmacist if taken or might take any other m increase the risk of getting side
you are taking, have recently edicines. Some medicines may effects.
Your doctor may tell you to take a lower dose if you are taking other medicines (listed in section 2) or if you have severe kidney problems. Speak to your doctor if you are undergoing dialysis.
The following is a list of exampl your doctor to lower the dose of • ketoconazole, itraconazole,
es of medicines that may require AQUIPTA:
voriconazole, clarithromycin, edicines used to treat fungal or
telithromycin, rifampicin (m bacterial infections)
atazanavir, indinavir, nelfina
vir, ritonavir, saquinavir,
How to take
AQUIPTA may be taken with or without food.
If you take more AQUIPTA than you should
If you have used more AQUIPTA than you should, tell your doctor.
tipranavir (medicines used • ciclosporin (medicine that a • telmisartan (medicine used
to treat HIV)
ffects your immune system) to treat high blood pressure)
If any of the above apply to you doctor or pharmacist before tak
or you are not sure, talk to your ing AQUIPTA.
If you forget to take AQUIPTA
If you take AQUIPTA for the prevention of migraine and forget to take it:
A missed dose should be taken straight away. If it is close to your scheduled next dose, do not take a double dose to make up for a forgotten tablet.
If you stop taking AQUIPTA
If you take AQUIPTA for the prevention of migraine, do not stop using it without talking to your doctor first. Your symptoms may return if you stop the treatment.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Serious side effects
Stop taking AQUIPTA and contact your doctor immediately if you have any of the following symptoms, which may be part of
a serious allergic reaction:
- difficulty breathing
- swelling of the face
- rash, itching, or hives
Other side effects
Tell your doctor or nurse if you notice any of the following side effects:
Common (may affect up to 1 in 10 people)
- feeling sick (nausea)
- constipation
- tiredness (fatigue) or sleepiness (somnolence) • decreased appetite
- weight loss
Uncommon (may affect up to 1 in 100 people) • increased levels of liver enzymes
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme.
Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
By reporting side effects, you can help provide more information on the safety of this medicine.
Mock-Up-Package-Leaflet-Aquipta-10mg + 60mg
5. How to store AQUIPTA
Keep this medicine out of the si
ght and reach of children.
This medicinal product does no conditions.
t require any special storage
Do not use this medicine after t the carton and blister after EXP day of that month.
he expiry date which is stated on . The expiry date refers to the last
Do not throw away any medicin waste. Ask your pharmacist ho you no longer use. These meas environment.
es via wastewater or household w to throw away medicines ures will help to protect the
6. Contents of the pack and
other information
What AQUIPTA contains
The active substance is atogep
ant.
Each tablet contains either • The other ingredients are:
10 mg or 60 mg of atogepant. Polyvinylpyrrolidone/Vinyl E polyethylene glycol succinate, ellulose, sodium chloride, lloidal silicon dioxide and
acetate copolymer, vitamin mannitol, microcrystalline c croscarmellose sodium, co sodium stearyl fumarate.
What AQUIPTA looks like an
d contents of the pack
AQUIPTA 10 mg tablets AQUIPTA 10 mg tablet is a whit tablet debossed with “A” and “1
e to off-white, round biconvex 0” on one side.
AQUIPTA 60 mg tablets AQUIPTA 60 mg tablet is a whit tablet debossed with “A60” on o
e to off-white, oval biconvex ne side.
For packs of 2 tablets, each blis
ter contains 2 tablets.
For packs of 7, 28 or 98 tablets
, each blister contains 7 tablets.
Not all pack sizes may be mark
eted.
Marketing Authorisation Hol
der
AbbVie Ltd
Maidenhead
SL6 4UB
UK
Tel: +44 (0) 1628 561090
Manufacturer
AbbVie S.r.l
S.R. 148 Pontina Km 52 Snc
Campoverde di Aprilia, Latina 04011
Italy
This leaflet was last revised in November 2025.
To listen to or request a copy of this leaflet in Braille, large print or audio, please contact the Marketing Authorisation Holder.